Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Canntab Therapeutics Ltd
CTABF
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and...
consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:CTABF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Jan 31, 2020 1:57pm
RE:RE:RE:?????????
many thanks sharing this email. Did Canntab also mention about sales license?
(5)
•••
Mellymelrascal
X
View Profile
View Bullboard History
Comment by
Mellymelrascal
on Jan 30, 2020 7:36am
RE:RE:?????????
Sent an email to canntab for an update on when products will hit shelves, here was the reply "Hi, We submitted our evidence package to Health Canada last month, and we expect their review process
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jan 29, 2020 10:41am
Fins on sedar
Working capital at Nov 30 was $34,771. How is this co. staying solvent? PP must be coming.
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Jan 28, 2020 5:20pm
RE:?????????
Canntab recieved license for production on 23, December. I heard that it takes at least 7 weeks till next license. Than it will be on 7, February! People
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Jan 23, 2020 3:39am
RE:?????????
yes...terrible
(39)
•••
Sensanome
X
View Profile
View Bullboard History
Post by
Sensanome
on Jan 11, 2020 12:03pm
Zacks January 09 2020 Report.. Puts FSD at a 18.50$ USD
Zacks January 09 2020 Report.. Puts FSD at a 18.50$ USD prive Evaluation. Read report in link below! https://s1.q4cdn.com/460208960/files/News/2020/Zacks_SCR_Research_01092020_CN.HUGE_Ralston.pdf
...more
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Dec 24, 2019 7:47am
RE:Canntab News!!!!!!!!!!
but why is this so falling on this great news ?? I wonder
(1)
•••
JoeLeclerc42
X
View Profile
View Bullboard History
Post by
JoeLeclerc42
on Dec 23, 2019 2:35am
Canntab News!!!!!!!!!!
Check it out https://cutt.ly/OreHC7l
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Post by
fromBelgien
on Dec 16, 2019 10:05am
Any news?
fsd has huge news.. and what's wrong with Canntab ??????
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Nov 26, 2019 10:30am
RE:Do we now have to wait for FDA to approve the tablets?
would love to know too .. I just wonder why it takes such a long time till Canntab receives sales license Does anyone know why!?
(4)
•••
Mindfull
X
View Profile
View Bullboard History
Post by
Mindfull
on Nov 24, 2019 11:08pm
Do we now have to wait for FDA to approve the tablets?
In order to sell in USA with Exactus.
(0)
•••
666supreme66666
X
View Profile
View Bullboard History
Comment by
666supreme66666
on Nov 21, 2019 7:42am
RE:RE:Canntab in Play
just 25 million shares ..........
(0)
•••
666supreme66666
X
View Profile
View Bullboard History
Comment by
666supreme66666
on Nov 21, 2019 7:40am
RE:Canntab in Play
the company becomes a beautiful prey for the big we may be going to $ 2.00
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Nov 20, 2019 4:27pm
PP coming?
At Aug 31 working capital was $571,040 which must be gone by now. How is this co. stating liquid?
(1)
•••
Eppy
X
View Profile
View Bullboard History
Comment by
Eppy
on Nov 20, 2019 12:47pm
RE:RE:Halted
The company just posted a NR indicating that it has entered into a suppy and distribution agreement with a company in Florida.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >